Focus Investment Banking

MAY 20, 2024

The JML transaction is the latest in a long line of successful deals Bob has negotiated for clients throughout the years. in $8B transaction), howstuffworks.com International (merged into NASDAQ company), Global Metro Networks, MetroNet (IPO), Performance Awareness Corp. IPO), and Megapath Communications.

M&A 52

M&A Mergers and Acquisitions IPO Financial Transaction 52

Cooley M&A

NOVEMBER 1, 2018

In spite of a general environment of political and economic uncertainty and a daily sprinkling of stock market volatility, trade wars, sanctions, the U.S. government shutdown disrupting the market for IPOs, Brexit uncertainty, natural disasters and various other crises, cross-border M&A activity momentum continues. The current U.S./China

M&A 52

M&A Mergers and Acquisitions Government Business 52

Cooley M&A

JANUARY 25, 2023

Although there were 104 initial public offerings of biotechnology companies in 2021 that raised nearly $15 billion in funds, 2022 saw only 22 such IPOs collectively raising less than $2 billion. Novartis announced plans to spin off its generics and biosimilars division into a publicly traded stand-alone company. Let’s dig in.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Collaboration 40

Cooley M&A

JANUARY 20, 2022

On the other side of the negotiating table, however, we still don’t take as a given that strategic acquirers blanketly utilize insurance products. The volume of SPAC IPOs in 2021 shattered previous records, but most came in the first quarter, with more SPAC IPOs in the first quarter of 2021 (298) than all of 2020 combined (248).

M&A 40

M&A Insurance Mergers and Acquisitions IPO 40

Cooley M&A

JANUARY 25, 2023

In the US, the Federal Trade Commission and the Department of Justice under the Biden administration have shifted their priorities and rhetoric in favor of tougher enforcement, with consolidation in the tech sector being one of their top targets.

M&A 52

M&A Mergers and Acquisitions Private Equity Mergers 52

Cooley M&A

JANUARY 20, 2022

Certain headwinds and other complicating factors, however, may have tamped down M&A activity in 2021, including: Antitrust regulators continuing to produce uncertainty, with the Federal Trade Commission announcing a number of key policy changes – the full impact of these policy changes on transactions remains to be seen.

M&A 40

M&A Mergers and Acquisitions Pharmaceutical Mergers 40

MergersCorp M&A International

MAY 27, 2025

The Basics At its core, a SPAC is a shell company with no commercial operations, formed solely to raise capital through an Initial Public Offering (IPO) with the express purpose of acquiring an existing private company. If approved, the private company effectively becomes the publicly traded entity, inheriting the SPAC’s listing.

IPO 52

IPO Mergers and Acquisitions Investors Capital 52

Cooley M&A

JANUARY 22, 2025

This approach, combining M&A and initial public offering (IPO) preparations on parallel tracks, allows companies to maximize optionality in an uncertain market. Of course, the targets leverage in the M&A track of a dual-track process inherently increases when the IPO track is a viable strategy.

M&A 64

M&A Mergers and Acquisitions Pharmaceutical Acquisitions 64

Cooley M&A

FEBRUARY 3, 2025

The tech deal floodgates still havent opened, as persistent valuation mismatches, a still (mostly) closed tech IPO market, stiff competition and worldwide regulatory scrutiny continue to weigh on activity, particularly for VC-backed exits and mega deals. billion acquisition of Altair, IBMs pending $6.4 So is tech M&A back?

M&A 59

M&A Mergers and Acquisitions Private Equity Acquisitions 59